Anti-obesity Medication Market Analysis 2024-2034 by Product, Mechanism of Action, Distribution Channel and Region - Global Industry Projected to Register 31.71% CAGR, Reaching $137.4 Billion by 2034
June 26, 2024 06:55 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market" report has been added to ResearchAndMarkets.com's offering.The global anti-obesity medication market accounted...
Anti-Obesity Drugs Global Strategic Business Report 2024: Market to Reach $4.8 Billion by 2030 - Saxenda Commands the AOM Market, Newer Drugs to Provide Impetus to Market Growth
May 07, 2024 10:41 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Anti-Obesity Drugs Market to...
Global Anti-obesity Medication Market Trends Analysis Report 2024-2030: Social Media Influences and Strategic Partnerships, Mergers, Acquisitions, and Collaborations Shaping the Landscape
April 11, 2024 11:14 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market Size, Share & Trends Analysis Report" report has been added to ResearchAndMarkets.com's offering.The global...
Anti-Obesity Drug Market to Witness Robust Growth Through 2028 Amid Rising Global Obesity Concerns
December 20, 2023 10:38 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Anti-obesity Drug Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.The anti-obesity drug market is...
![Diet Doc Logo](/news-release/logo/302768/0/302768.jpg?lastModified=12%2F09%2F2016%2022%3A39%3A27&size=2)
Diet Doc Patients Thought to Lose More Weight Than Contrave or Belviq Patients Without Dangerous Prescription Drug Side Effects
January 23, 2015 07:00 ET
|
Diet Doc Weight Loss
NEW YORK, Jan. 23, 2015 (GLOBE NEWSWIRE) -- Internet reports claiming that the Endocrine Society is now recommending prescription drugs to accompany diet plans for obese patients offer two drug...
![Diet Doc Logo](/news-release/logo/302768/0/302768.jpg?lastModified=12%2F09%2F2016%2022%3A39%3A27&size=2)
Diet Doc Announces Medical Diet Plans and Human Growth Hormone (hGH) for Better Weight Loss Than Contrave
September 15, 2014 07:00 ET
|
Diet Doc Weight Loss
LOS ANGELES, Sept. 15, 2014 (GLOBE NEWSWIRE) -- The FDA recently approved Contrave, a weight loss drug being marketed for those who are obese and have, at least, one other accompanying illness....